U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)
U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. Management is pursuing hospital partnerships and shifting toward private insurance, aiming to boost clinic utilization and reduce reliance on Medicare/Medicaid.
U.S. Physical Therapy, Inc. (USPH) Q1 2026 Earnings Call Transcript
U.S. Physical Therapy, Inc. (USPH) Q1 2026 Earnings Call Transcript
U.S. Physical Therapy (USPH) Q1 Earnings and Revenues Lag Estimates
U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.46 per share, missing the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.48 per share a year ago.
Here's What Key Metrics Tell Us About U.S. Physical Therapy (USPH) Q1 Earnings
While the top- and bottom-line numbers for U.S. Physical Therapy (USPH) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Analysts Set U.S. Physical Therapy, Inc. (NYSE:USPH) Target Price at $104.50
U.S. Physical Therapy, Inc. (NYSE: USPH - Get Free Report) has received an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy
Wall Street Analysts Believe U.S. Physical Therapy (USPH) Could Rally 26.52%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in U.S. Physical Therapy (USPH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
U.S. Physical Therapy, Inc. (USPH) Q4 2025 Earnings Call Transcript
U.S. Physical Therapy, Inc. (USPH) Q4 2025 Earnings Call Transcript
Is the Options Market Predicting a Spike in U.S. Physical Therapy Stock?
Investors need to pay close attention to USPH stock based on the movements in the options market lately.
U.S. Physical Therapy, Inc. (USPH) Q3 2025 Earnings Call Transcript
U.S. Physical Therapy, Inc. ( USPH ) Q3 2025 Earnings Call November 6, 2025 10:30 AM EST Company Participants Christopher Reading - CEO & Chairman Jason Curtis Carey Hendrickson - Chief Financial Officer Eric Williams - President & COO Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Joanna Gajuk - BofA Securities, Research Division Lawrence Solow - CJS Securities, Inc. Constantine Davides - Citizens JMP Securities, LLC, Research Division Michael Petusky - Barrington Research Associates, Inc., Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the U.S. Physical Therapy Third Quarter 2025 and Full Year Earnings Conference Call.
U.S. Physical Therapy (USPH) Q3 Earnings Miss Estimates
U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.66 per share, missing the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.69 per share a year ago.
Does U.S. Physical Therapy (USPH) Have the Potential to Rally 26.48% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in U.S. Physical Therapy (USPH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
U.S. Physical Therapy, Inc. (USPH) Q2 2025 Earnings Call Transcript
U.S. Physical Therapy, Inc. (NYSE:USPH ) Q2 2025 Earnings Conference Call August 7, 2025 10:30 AM ET Company Participants Carey P. Hendrickson - Chief Financial Officer Christopher J.
